Rollout Map
Sign Up
H.R. 27 House Crime and Law Enforcement

HALT Fentanyl Act

Introduced
Jan 3, 2025
Sponsor
Rep. Griffith, H. Morgan (R-VA-9)
View on Congress.gov

STAGE 4 OF 8 — HOUSE FLOOR

Currently in the House. Last action: received in the senate and read twice and referred to the committee on the judiciary on Feb 10, 2025.

  1. House Introduced in House Jan 3, 2025
  2. House Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Jan 3, 2025
  3. House Rules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report. Feb 4, 2025
  4. House Rule H. Res. 93 passed House. Feb 5, 2025
  5. House Considered under the provisions of rule H. Res. 93. (consideration: CR H520-533) Feb 6, 2025
  6. House Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report. Feb 6, 2025
  7. House DEBATE - The House proceeded with one hour of debate on H.R. 27. Feb 6, 2025
  8. House DEBATE - Pursuant to the provisions of H. Res. 93, the House proceeded with 10 minutes of debate on the Trahan amendment No. 2. Feb 6, 2025
  9. House POSTPONED PROCEEDINGS - At the conclusion of debate on the Trahan amendment No. 2, the Chair put the question on agreeing to the amendment and by voice vote, announced that the noes prevailed. Mrs. Trahan demanded the yeas and nays and the Chair postponed further proceeding until a time to be announced. Feb 6, 2025
  10. House Considered as unfinished business. (consideration: CR H533-535) Feb 6, 2025
  11. House Passed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522) Feb 6, 2025
  12. House On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522) Feb 6, 2025
  13. House Motion to reconsider laid on the table Agreed to without objection. Feb 6, 2025
  14. House
    On Passage Feb 6, 2025
    Agreed Yea 312 Nay 108 Roll Call
  15. Senate Received in the Senate and Read twice and referred to the Committee on the Judiciary. Feb 10, 2025

Cosponsors

61

Subjects

Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrationsResearch administration and funding

Committees

  • Judiciary Committee
    • Referred To , Feb 10, 2025
  • Judiciary Committee
    • Referred To , Jan 3, 2025
  • Energy and Commerce Committee
    • Referred To , Jan 3, 2025

Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for certain schedule I research.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Summary as of: Introduced in House

Bill Text

Formatted Text PDF Formatted XML

Related Bills

Comments · 0

Loading comments...